|
5' Cap
|
130 |
Microbial Genetics |
|
Acid
|
21 |
Foundations |
|
Acid-Fast Cell Walls
|
35, 39, 51 |
Foundations; Prokaryote & Eukoaryote Cells |
|
Acid-Fast Stain
|
35, 39 |
Foundations |
|
Acidic Dye
|
34 |
Foundations |
|
Acidophiles
|
117 |
Microbial Growth |
|
Acne
|
370 |
Infections- Skin & Eye System |
|
Acquired Immodeficiency Syndrome (AIDS)
|
323 |
Infections- Cardiovascular System |
|
Acquired Immunity
|
220, 230 - 245 |
Disease, Immunity & Epidemiology |
|
Activator
|
147 |
Microbial Genetics |
|
Active Artificial Immunity
|
244 |
Disease, Immunity & Epidemiology |
|
Active Natural Immunity
|
244 |
Disease, Immunity & Epidemiology |
|
Active Site
|
78 - 81 |
Microbial Metabolism |
|
Active Transport
|
67 |
Prokaryote & Eukoaryote Cells |
|
Acute Disease
|
209 |
Disease, Immunity & Epidemiology |
|
Acute Phase Proteins
|
223 |
Disease, Immunity & Epidemiology |
|
Adenosine Triphosphate (ATP)
|
76 |
Microbial Metabolism |
|
Adherence Factors
|
218 |
Disease, Immunity & Epidemiology |
|
Adpative Immunity
|
220, 230 - 245 |
Disease, Immunity & Epidemiology |
|
Aerobic Respiration
|
83 - 91, 93 |
Microbial Metabolism |
|
Aerotolerant Anaerobes
|
114-115 |
Microbial Growth |
|
African Trypanosomiasis
|
338 |
Infections- Nervous System |
|
Agarose Gel Electrophoresis
|
159 - 160 |
Microbial Genetics |
|
Agglutination
|
234 |
Disease, Immunity & Epidemiology |
|
Agglutination Test
|
181, 251 |
Acellular Infectious Agents; Disease, Immunity & Epidemiology |
|
Agranulocytes
|
226 |
Disease, Immunity & Epidemiology |
|
Airborne Transmission
|
214 |
Disease, Immunity & Epidemiology |
|
Alcohol Fermentation
|
92 - 93 |
Microbial Metabolism |
|
Alcohols
|
188 |
Control of Microbial Growth |
|
Algae
|
12 |
Foundations |
|
Alkalating Agents
|
189 |
Control of Microbial Growth |
|
Alkaline
|
21 |
Foundations |
|
Alkaliphiles
|
117 |
Microbial Growth |
|
Allosteric Inhibitor
|
80 |
Microbial Metabolism |
|
Alternative Pathway (Complement Activation)
|
224 |
Disease, Immunity & Epidemiology |
|
Amensalism
|
216 |
Disease, Immunity & Epidemiology |
|
American Trypanosomiasis
|
326 |
Infections- Cardiovascular System |
|
Ames Test
|
141 |
Microbial Genetics |
|
Aminoglycosides
|
194 |
Control of Microbial Growth |
|
Anabolism
|
74 |
Microbial Metabolism |
|
Anaerobic Respiration
|
83 - 93 |
Microbial Metabolism |
|
Analytical Epidemiology
|
256 |
Disease, Immunity & Epidemiology |
|
Anion
|
17 |
Foundations |
|
Anoxygenic Photosynthesis
|
96 |
Microbial Metabolism |
|
Antagonism
|
192 |
Control of Microbial Growth |
|
Anthrax
|
374 |
Infections- Skin & Eye System |
|
Antibiotic Resistance
|
201 - 202 |
Control of Microbial Growth |
|
Antibody
|
231 - 234 |
Disease, Immunity & Epidemiology |
|
Antibody Classes
|
233 |
Disease, Immunity & Epidemiology |
|
Antibody-Dependent Cell-Mediated Cytotoxicity
|
234 |
Disease, Immunity & Epidemiology |
|
Antifungal Medications
|
199 |
Control of Microbial Growth |
|
Antigen
|
231 - 232, 234 |
Disease, Immunity & Epidemiology |
|
Antigen-Antibody Interactions
|
234 |
Disease, Immunity & Epidemiology |
|
Antigen-Presenting Cell (APC)
|
226, 235 |
Disease, Immunity & Epidemiology |
|
Antigenic Variation
|
218 |
Disease, Immunity & Epidemiology |
|
Antihelminthic Medications
|
198 |
Control of Microbial Growth |
|
Antimicrobial Peptides
|
223 |
Disease, Immunity & Epidemiology |
|
Antiprotozoal Medications
|
198 |
Control of Microbial Growth |
|
Antisepsis
|
183 |
Control of Microbial Growth |
|
Antiviral Medications
|
199 |
Control of Microbial Growth |
|
Apoenzyme
|
78 - 79 |
Microbial Metabolism |
|
Apoptosis
|
226, 238 |
Disease, Immunity & Epidemiology |
|
Arboviral Encephalitis
|
333 |
Infections- Nervous System |
|
Archaea
|
6, 10 |
Foundations |
|
Ascaris lumbricoides
|
258 |
Microbes |
|
Aspergillosis
|
308 |
Infections- Respiratory System |
|
Aspergillus spp.
|
258 |
Microbes |
|
Asymptomatic
|
205 |
Disease, Immunity & Epidemiology |
|
Atomic Structure
|
16 |
Foundations |
|
Autoclave
|
185 |
Control of Microbial Growth |
|
Autoimmune Disorder
|
246 |
Disease, Immunity & Epidemiology |
|
Autotroph
|
82 |
Microbial Metabolism |
|
B Cells
|
230, 236 - 237 |
Disease, Immunity & Epidemiology |
|
Bacillary Dysentery
|
345 |
Infections- Gastrointestinal System |
|
Bacillus
|
42, 44 |
Prokaryote & Eukoaryote Cells |
|
Bacillus anthracis
|
258 |
Microbes |
|
Bacterial Growth Curve
|
104 |
Microbial Growth |
|
Bacterial Growth Phases
|
103-104 |
Microbial Growth |
|
Bacterial Safety Levels (BSLs)
|
204 |
Control of Microbial Growth |
|
Bacterial Vaginosis (BV)
|
362 |
Infections- Genitourinary System |
|
Bactericidal
|
191 |
Control of Microbial Growth |
|
Bacteriophage
|
164, 168 - 173, 181 |
Acellular Infectious Agents |
|
Bacteriostatic
|
191 |
Control of Microbial Growth |
|
Bartonella henselae
|
259 |
Microbes |
|
Base
|
21 |
Foundations |
|
Basic Dye
|
34 |
Foundations |
|
Basic Reproduction Number
|
255 |
Disease, Immunity & Epidemiology |
|
Basophils
|
226 |
Disease, Immunity & Epidemiology |
|
Bilharzia
|
327 |
Infections- Cardiovascular System |
|
Binary Fission
|
101-102 |
Microbial Growth |
|
Biofilms
|
112 |
Microbial Growth |
|
Biogenesis
|
1 |
Foundations |
|
Biogeochemical Cycles
|
97-100 |
Microbial Metabolism |
|
Biological Vector
|
214 |
Disease, Immunity & Epidemiology |
|
Bionomial Nomenclature
|
5 |
Foundations |
|
Biotechnology
|
153 - 163 |
Microbial Genetics |
|
Bisbiguanides
|
189 |
Control of Microbial Growth |
|
Blue-White Screening
|
158 |
Microbial Genetics |
|
Blunt Ends
|
154 - 155 |
Microbial Genetics |
|
Bordetella pertussis
|
259 |
Microbes |
|
Borrelia burgdorferi
|
259 |
Microbes |
|
Botulism
|
330 |
Infections- Nervous System |
|
Bridge Reaction
|
86 |
Microbial Metabolism |
|
Brightfield Microscope
|
29 - 30 |
Foundations |
|
Broad-Spectrum
|
191 |
Control of Microbial Growth |
|
Brucella spp.
|
260 |
Microbes |
|
Brucellosis
|
312 |
Infections- Cardiovascular System |
|
Bubonic Plague
|
314 |
Infections- Cardiovascular System |
|
Burst
|
179 - 180 |
Acellular Infectious Agents |
|
Burst Size
|
179 - 180 |
Acellular Infectious Agents |
|
Calvin Cycle
|
95 |
Microbial Metabolism |
|
Campylobacter jejuni
|
260 |
Microbes |
|
Campylobacteriosis
|
350 |
Infections- Gastrointestinal System |
|
Candida albicans
|
260 |
Microbes |
|
Capnophiles
|
114 |
Microbial Growth |
|
Capsid
|
165 |
Acellular Infectious Agents |
|
Capsule
|
35, 40, 53, 218 |
Foundations; Prokaryote & Eukoaryote Cells; Disease, Immunity & Epidemiology |
|
Capsule Stain
|
35, 40 |
Foundations |
|
Carbapenems
|
193 |
Control of Microbial Growth |
|
Carbohydrates
|
25 |
Foundations |
|
Carbon Cycle
|
97 |
Microbial Metabolism |
|
Carrier
|
212 |
Disease, Immunity & Epidemiology |
|
Cat Scratch Disease
|
313 |
Infections- Cardiovascular System |
|
Catabolism
|
74 |
Microbial Metabolism |
|
Cation
|
17 |
Foundations |
|
Cell Shapes & Configurations
|
42 - 44 |
Prokaryote & Eukoaryote Cells |
|
Cell Wall Inhibitors
|
193 |
Control of Microbial Growth |
|
Cell Walls
|
51 - 52, 63 |
Prokaryote & Eukoaryote Cells |
|
Cellular Immunity
|
230, 238 - 242 |
Disease, Immunity & Epidemiology |
|
Cellular Respiration
|
83 - 93 |
Microbial Metabolism |
|
Centers for Disease Control (CDC)
|
257 |
Disease, Immunity & Epidemiology |
|
Central Dogma of Molecular Biology
|
123 |
Microbial Genetics |
|
Centrosomes
|
59 |
Prokaryote & Eukoaryote Cells |
|
Cephalosporins
|
193 |
Control of Microbial Growth |
|
Chagas Disease
|
326 |
Infections- Cardiovascular System |
|
Chemical Bonds
|
18 |
Foundations |
|
Chemical Fixation
|
33 |
Foundations |
|
Chemical Food Preservatives
|
189 |
Control of Microbial Growth |
|
Chemical Mutagens
|
138 |
Microbial Genetics |
|
Chemical Reactions
|
73 - 75 |
Microbial Metabolism |
|
Chemically Defined Media
|
119 |
Microbial Growth |
|
Chemiosmosis
|
89 - 91 |
Microbial Metabolism |
|
Chemotroph
|
82 |
Microbial Metabolism |
|
Chickenpox
|
304 |
Infections- Respiratory System |
|
Chikungunya Fever
|
321 |
Infections- Cardiovascular System |
|
Chlamydia
|
364 |
Infections- Genitourinary System |
|
Chlamydia trachomatis
|
261 |
Microbes |
|
Chloroplasts
|
62, 65 - 66 |
Prokaryote & Eukoaryote Cells |
|
Cholera
|
349 |
Infections- Gastrointestinal System |
|
Chromatin
|
58 |
Prokaryote & Eukoaryote Cells |
|
Chromophore
|
34 |
Foundations |
|
Chromosomes
|
58 |
Prokaryote & Eukoaryote Cells |
|
Chronic Disease
|
209 |
Disease, Immunity & Epidemiology |
|
Chronic Viral Infection
|
178 |
Acellular Infectious Agents |
|
Cilia
|
64, 221 |
Prokaryote & Eukoaryote Cells; Disease, Immunity & Epidemiology |
|
Citric Acid Cycle
|
87 - 88 |
Microbial Metabolism |
|
Classical Pathway (Complement Activation)
|
224 |
Disease, Immunity & Epidemiology |
|
Clostridioides difficile
|
261 |
Microbes |
|
Clostridioides difficile Infection
|
353 |
Infections- Gastrointestinal System |
|
Clostridium botulinum
|
262 |
Microbes |
|
Clostridium difficle
|
261 |
Microbes |
|
Clostridium difficle Infection
|
353 |
Infections- Gastrointestinal System |
|
Clostridium perfringens
|
262 |
Microbes |
|
Clostridium perfringens Gastroenteritis
|
352 |
Infections- Gastrointestinal System |
|
Clostridium tetani
|
262 |
Microbes |
|
Coccidioides immitis
|
263 |
Microbes |
|
Coccidioidomycosis
|
307 |
Infections- Respiratory System |
|
Coccobacillus
|
42 |
Prokaryote & Eukoaryote Cells |
|
Coccus
|
42 - 43 |
Prokaryote & Eukoaryote Cells |
|
Codons
|
131 - 132 |
Microbial Genetics |
|
Coenzyme
|
78 - 79 |
Microbial Metabolism |
|
Cofactor
|
78 - 79 |
Microbial Metabolism |
|
Cold Sores
|
378 |
Infections- Skin & Eye System |
|
Commensalism
|
216 |
Disease, Immunity & Epidemiology |
|
Commerical Sterilization
|
183 |
Control of Microbial Growth |
|
Common Cold
|
298 |
Infections- Respiratory System |
|
Common Source Spread
|
253 |
Disease, Immunity & Epidemiology |
|
Communicable Disease
|
206 |
Disease, Immunity & Epidemiology |
|
Competitive Inhibitor
|
80 - 81 |
Microbial Metabolism |
|
Complement Activation
|
224, 234 |
Disease, Immunity & Epidemiology |
|
Complement Fixation Test
|
251 |
Disease, Immunity & Epidemiology |
|
Complement System
|
224 - 225 |
Disease, Immunity & Epidemiology |
|
Complex Media
|
119 |
Microbial Growth |
|
Confocal Microscope
|
32 |
Foundations |
|
Conjugate Vaccine
|
245 |
Disease, Immunity & Epidemiology |
|
Conjugation
|
142 - 145 |
Microbial Genetics |
|
Conjunctivitis
|
376 |
Infections- Skin & Eye System |
|
Contagious Disease
|
206 |
Disease, Immunity & Epidemiology |
|
Contrast
|
28 |
Foundations |
|
Coronavirus Disease 2019
|
301 |
Infections- Respiratory System |
|
Corynebacterium diphtheriae
|
263 |
Microbes |
|
Covalent Bond
|
18 |
Foundations |
|
COVID-19
|
301 |
Infections- Respiratory System |
|
Crenation
|
69 |
Prokaryote & Eukoaryote Cells |
|
Creutzfeldt-Jakob Disease
|
337 |
Infections- Nervous System |
|
CRISPR
|
161 |
Microbial Genetics |
|
Cryptococcus neoformans
|
263 |
Microbes |
|
Cryptosporidiosis
|
357 |
Infections- Gastrointestinal System |
|
Cryptosporidium spp.
|
264 |
Microbes |
|
Culture Media
|
119 |
Microbial Growth |
|
Cutibacterium acnes
|
264 |
Microbes |
|
Cysticercosis
|
339 |
Infections- Nervous System |
|
Cystitis
|
360 |
Infections- Genitourinary System |
|
Cytokines
|
223 |
Disease, Immunity & Epidemiology |
|
Cytomegalovirus
|
264 |
Microbes |
|
Cytomegalovirus Disease
|
318 |
Infections- Cardiovascular System |
|
Cytopathic Effects
|
181 |
Acellular Infectious Agents |
|
Cytoplasm
|
46, 59 |
Prokaryote & Eukoaryote Cells |
|
Cytoskeleton
|
59 |
Prokaryote & Eukoaryote Cells |
|
Cytotoxic T Cells
|
238, 241 - 242 |
Disease, Immunity & Epidemiology |
|
Dark Repair
|
139 |
Microbial Genetics |
|
Darkfield Microscope
|
31 |
Foundations |
|
Death Phase
|
103-104 |
Microbial Growth |
|
Decimal Reduction Time (DRT)
|
184 |
Control of Microbial Growth |
|
Decomposition Reaction
|
73 |
Microbial Metabolism |
|
Degeneracy
|
131 |
Microbial Genetics |
|
Degerming
|
183 |
Control of Microbial Growth |
|
Deinococcus radiodurans
|
265 |
Microbes |
|
Dendritic Cells
|
226 |
Disease, Immunity & Epidemiology |
|
Dengue Fever
|
320 |
Infections- Cardiovascular System |
|
Dengue virus
|
265 |
Microbes |
|
Dental Caries
|
341 |
Infections- Gastrointestinal System |
|
Deoxyribonucleic Acid (DNA)
|
27, 120 - 130 |
Foundations; Microbial Genetics |
|
Dermatophytosis
|
383 |
Infections- Skin & Eye System |
|
Descriptive Epidemiology
|
256 |
Disease, Immunity & Epidemiology |
|
Dessication
|
186 |
Control of Microbial Growth |
|
Diagnostic Immunology
|
251 |
Disease, Immunity & Epidemiology |
|
Diarrheagenic E. coli
|
348 |
Infections- Gastrointestinal System |
|
Differential Interference Microscope
|
31 |
Foundations |
|
Differential Media
|
119 |
Microbial Growth |
|
Differential Stain
|
34 - 41 |
Foundations |
|
Diffusion
|
67 |
Prokaryote & Eukoaryote Cells |
|
Dilution Test
|
203 |
Control of Microbial Growth |
|
Dimorphic Fungi
|
14 |
Foundations |
|
Diphtheria
|
293 |
Infections- Respiratory System |
|
Diplobacilli
|
44 |
Prokaryote & Eukoaryote Cells |
|
Diplococci
|
43 |
Prokaryote & Eukoaryote Cells |
|
Direct Cell Count
|
106 |
Microbial Growth |
|
Direct Contact Transmission
|
213 |
Disease, Immunity & Epidemiology |
|
Direct Measurement of Bacterial Growth
|
106-110 |
Microbial Growth |
|
Direct Repair
|
139 |
Microbial Genetics |
|
Disease
|
205 - 214 |
Disease, Immunity & Epidemiology |
|
Disinfection
|
183 |
Control of Microbial Growth |
|
Disk-Diffusion Test
|
190, 203 |
Control of Microbial Growth |
|
DNA
|
27, 120 - 130 |
Foundations; Microbial Genetics |
|
DNA Ligase
|
125 - 126 |
Microbial Genetics |
|
DNA Polymerase
|
124 - 126 |
Microbial Genetics |
|
DNA Probe
|
161 |
Microbial Genetics |
|
Domain System
|
6 |
Foundations |
|
Donor (F+) Cells
|
144 - 145 |
Microbial Genetics |
|
Dosage
|
192 |
Control of Microbial Growth |
|
Double Replacement Reaction
|
73 |
Microbial Metabolism |
|
Double-Stranded DNA Virus (dsDNA)
|
177 |
Acellular Infectious Agents |
|
Double-Stranded RNA Virus (dsRNA)
|
176 |
Acellular Infectious Agents |
|
Dracunculus medinensis
|
265 |
Microbes |
|
Droplet Transmission
|
213 |
Disease, Immunity & Epidemiology |
|
Dry Heat Sterilization
|
185 |
Control of Microbial Growth |
|
Dyes
|
34 |
Foundations |
|
Ebola Disease
|
322 |
Infections- Cardiovascular System |
|
Ebolaviruses
|
266 |
Microbes |
|
Eclipse Phase
|
179 - 180 |
Acellular Infectious Agents |
|
Electron
|
16 |
Foundations |
|
Electron Carriers
|
76 |
Microbial Metabolism |
|
Electron Microscope
|
32 |
Foundations |
|
Electron Transport Chain
|
89 - 91 |
Microbial Metabolism |
|
Electronegativity
|
17 |
Foundations |
|
Emerging Infectious Diseases
|
257 |
Disease, Immunity & Epidemiology |
|
Encephalitis
|
333 |
Infections- Nervous System |
|
Endemic Disease
|
254 |
Disease, Immunity & Epidemiology |
|
Endergonic
|
74 |
Microbial Metabolism |
|
Endocytosis
|
72 |
Prokaryote & Eukoaryote Cells |
|
Endomembrane System
|
60 |
Prokaryote & Eukoaryote Cells |
|
Endoplasmic Reticulum
|
60 |
Prokaryote & Eukoaryote Cells |
|
Endospore Stain
|
35, 41 |
Foundations |
|
Endospores
|
47 - 48 |
Prokaryote & Eukoaryote Cells |
|
Endosymbiotic Theory
|
65 - 66 |
Prokaryote & Eukoaryote Cells |
|
Endotoxin
|
51, 218 - 219 |
Prokaryote & Eukoaryote Cells; Disease, Immunity & Epidemiology |
|
Energy Carriers
|
76 |
Microbial Metabolism |
|
Enrichment Media
|
119 |
Microbial Growth |
|
Enterobiasis
|
358 |
Infections- Gastrointestinal System |
|
Enterobius vermicularis
|
266 |
Microbes |
|
Envelope
|
165 |
Acellular Infectious Agents |
|
Enzyme-Linked Immunosorbant Assay (ELISA)
|
181, 251 - 252 |
Acellular Infectious Agents; Disease, Immunity & Epidemiology |
|
Enzyme-Substrate Binding
|
77 - 81 |
Microbial Metabolism |
|
Enzymes
|
77 - 81 |
Microbial Metabolism |
|
Eosinophils
|
226 |
Disease, Immunity & Epidemiology |
|
Epidemic Disease
|
254 |
Disease, Immunity & Epidemiology |
|
Epidemiology
|
253 - 257 |
Disease, Immunity & Epidemiology |
|
Epitopes
|
231 - 232 |
Disease, Immunity & Epidemiology |
|
Epsilometer (E-Test)
|
203 |
Control of Microbial Growth |
|
Epstein Barr Virus (EBV)
|
266 |
Microbes |
|
Erythema Infectiousum
|
380 |
Infections- Skin & Eye System |
|
Escherichia coli
|
267 |
Microbes |
|
Etiology
|
253 |
Disease, Immunity & Epidemiology |
|
Eukaryotes
|
6, 8, 57 - 64 |
Foundations; Prokaryote & Eukoaryote Cells |
|
Exergonic
|
74 |
Microbial Metabolism |
|
Exocytosis
|
72 |
Prokaryote & Eukoaryote Cells |
|
Exoenzymes
|
218 |
Disease, Immunity & Epidemiology |
|
Exons
|
130 |
Microbial Genetics |
|
Exotoxin
|
218 - 219 |
Disease, Immunity & Epidemiology |
|
Experimental Epidemiology
|
256 |
Disease, Immunity & Epidemiology |
|
Extracellular Matrix
|
63 |
Prokaryote & Eukoaryote Cells |
|
F Plasmid
|
144 - 145 |
Microbial Genetics |
|
Facilitated Diffusion
|
67 |
Prokaryote & Eukoaryote Cells |
|
Facultative Anaerobes
|
114-115 |
Microbial Growth |
|
Fatty Acids
|
26 |
Foundations |
|
Feedback Inhibition
|
80 |
Microbial Metabolism |
|
Fermentation
|
2, 92 - 93 |
Foundations; Microbial Metabolism |
|
Fever
|
229 |
Disease, Immunity & Epidemiology |
|
Fever Blisters
|
378 |
Infections- Skin & Eye System |
|
Fifth Disease
|
380 |
Infections- Skin & Eye System |
|
Filtration
|
186 |
Control of Microbial Growth |
|
Fimbriae
|
53 |
Prokaryote & Eukoaryote Cells |
|
Fixation
|
33 |
Foundations |
|
Flagella Stain
|
35 |
Foundations |
|
Flagellum/Flagella
|
54 - 56, 64 |
Prokaryote & Eukoaryote Cells |
|
Fleming, Alexander
|
3 |
Foundations |
|
Fluid Mosaic Model
|
49 |
Prokaryote & Eukoaryote Cells |
|
Fluorescence Microscope
|
32 |
Foundations |
|
Fluorescent Antibody Test
|
251 |
Disease, Immunity & Epidemiology |
|
Fluoroquinolones
|
195 |
Control of Microbial Growth |
|
Focal Infection
|
211 |
Disease, Immunity & Epidemiology |
|
Folliculitis
|
371 |
Infections- Skin & Eye System |
|
Fomite
|
213 |
Disease, Immunity & Epidemiology |
|
Foodborne Transmission
|
214 |
Disease, Immunity & Epidemiology |
|
Frameshift Mutation
|
136 - 137 |
Microbial Genetics |
|
Freezing
|
186 |
Control of Microbial Growth |
|
Fungi
|
6, 14 |
Foundations |
|
Gardnerella vaginalis
|
267 |
Microbes |
|
Gastric Juice
|
222 |
Disease, Immunity & Epidemiology |
|
Gastroenteritis (Viral)
|
354 |
Infections- Gastrointestinal System |
|
Gel Electrophoresis
|
159 - 160 |
Microbial Genetics |
|
Gene
|
123 |
Microbial Genetics |
|
Gene Expression
|
123 |
Microbial Genetics |
|
Gene Regulation
|
147 - 152 |
Microbial Genetics |
|
Generalized Transduction
|
142 - 143, 172 |
Microbial Genetics |
|
Generation Time
|
103 |
Microbial Growth |
|
Genetic Code
|
131 - 132 |
Microbial Genetics |
|
Genetic Engineering
|
153 - 163 |
Microbial Genetics |
|
Genotype
|
123 |
Microbial Genetics |
|
Germ Theory of Disease
|
3 |
Foundations |
|
German Measles
|
303 |
Infections- Respiratory System |
|
Germination
|
47 |
Prokaryote & Eukoaryote Cells |
|
Giardia lamblia (Giardia duodenalis)
|
268 |
Microbes |
|
Giardiasis
|
356 |
Infections- Gastrointestinal System |
|
Glycocalyx
|
53 |
Prokaryote & Eukoaryote Cells |
|
Glycolysis
|
83 - 85 |
Microbial Metabolism |
|
Golgi Apparatus
|
60 |
Prokaryote & Eukoaryote Cells |
|
Gonorrhea
|
363 |
Infections- Genitourinary System |
|
Gram Stain
|
35 - 38 |
Foundations |
|
Gram-Negative Cell Walls
|
51 - 52 |
Prokaryote & Eukoaryote Cells |
|
Gram-Positive Cell Walls
|
51 - 52 |
Prokaryote & Eukoaryote Cells |
|
Granulocytes
|
226 |
Disease, Immunity & Epidemiology |
|
Granzymes
|
226, 238 |
Disease, Immunity & Epidemiology |
|
Group Translocation
|
67 |
Prokaryote & Eukoaryote Cells |
|
Gyrase
|
124, 126 - 127 |
Microbial Genetics |
|
Haemophilus influenzae
|
268 |
Microbes |
|
Halobacterium spp.
|
268 |
Microbes |
|
Halogens
|
188 |
Control of Microbial Growth |
|
Halophiles
|
117 |
Microbial Growth |
|
Halotolerant
|
117 |
Microbial Growth |
|
Hand, Foot, & Mouth Disease
|
381 |
Infections- Skin & Eye System |
|
Hansen's Disease
|
332 |
Infections- Nervous System |
|
Hapten
|
231 |
Disease, Immunity & Epidemiology |
|
Heat Fixation
|
33 |
Foundations |
|
Heavy Metals
|
188 |
Control of Microbial Growth |
|
Helicase
|
124, 126 |
Microbial Genetics |
|
Helicobacter pylori
|
269 |
Microbes |
|
Helper T Cells
|
238 - 240 |
Disease, Immunity & Epidemiology |
|
Hepatitis (Viral)
|
355 |
Infections- Gastrointestinal System |
|
Hepatitis viruses
|
269 |
Microbes |
|
Herd Immunity
|
255 |
Disease, Immunity & Epidemiology |
|
Herpes (Genital)
|
366 |
Infections- Genitourinary System |
|
Herpes (Oral)
|
378 |
Infections- Skin & Eye System |
|
Herpes simplex virus (HSV)
|
270 |
Microbes |
|
Herpes Zoster
|
305 |
Infections- Respiratory System |
|
Heterotroph
|
82 |
Microbial Metabolism |
|
Histoplasma capsulatum
|
270 |
Microbes |
|
Histoplasmosis
|
306 |
Infections- Respiratory System |
|
Holoenzyme
|
78 - 79 |
Microbial Metabolism |
|
Hooke, Robert
|
1 |
Foundations |
|
Horizontal Gene Transfer
|
142 - 146 |
Microbial Genetics |
|
Host Range
|
164 |
Acellular Infectious Agents |
|
Human herpesvirus type 6
|
270 |
Microbes |
|
Human Immunodeficiency Virus (HIV)
|
271, 323 |
Microbes; Infections- Cardiovascular System |
|
Human Papillomavirus (HPV)
|
271, 367 |
Microbes; Infections- Genitourinary System |
|
Humoral Immunity
|
230 - 237 |
Disease, Immunity & Epidemiology |
|
Hydrogen Bond
|
18, 20 |
Foundations |
|
Hydrophilic
|
19 |
Foundations |
|
Hydrophobic
|
19 |
Foundations |
|
Hypersensitivity
|
246 |
Disease, Immunity & Epidemiology |
|
Hyperthermophiles
|
116 |
Microbial Growth |
|
Hypertonic Solution
|
68 - 71 |
Prokaryote & Eukoaryote Cells |
|
Hypotonic Solution
|
68 - 71 |
Prokaryote & Eukoaryote Cells |
|
Iatrogenic Disease
|
206 |
Disease, Immunity & Epidemiology |
|
IgA
|
233 |
Disease, Immunity & Epidemiology |
|
IgD
|
233 |
Disease, Immunity & Epidemiology |
|
IgE
|
233 |
Disease, Immunity & Epidemiology |
|
IgG
|
233 |
Disease, Immunity & Epidemiology |
|
IgM
|
233 |
Disease, Immunity & Epidemiology |
|
Immune System Disorders
|
246 - 247 |
Disease, Immunity & Epidemiology |
|
Immunodeficiency
|
247 |
Disease, Immunity & Epidemiology |
|
Impetigo
|
372 |
Infections- Skin & Eye System |
|
Inactivated Vaccine
|
245 |
Disease, Immunity & Epidemiology |
|
Incidence
|
253 |
Disease, Immunity & Epidemiology |
|
Inclusions
|
46 |
Prokaryote & Eukoaryote Cells |
|
Incubation Period
|
207 - 208 |
Disease, Immunity & Epidemiology |
|
Indirect Contact Transmission
|
213 |
Disease, Immunity & Epidemiology |
|
Indirect Measurement of Bacterial Growth
|
111 |
Microbial Growth |
|
Induced Mutations
|
136 |
Microbial Genetics |
|
Inducible Operon
|
151 - 152 |
Microbial Genetics |
|
Induction
|
170 |
Acellular Infectious Agents |
|
Infection
|
205 - 214 |
Disease, Immunity & Epidemiology |
|
Infectious Disease
|
206 - 214 |
Disease, Immunity & Epidemiology |
|
Infectious Dose (ID50)
|
217 |
Disease, Immunity & Epidemiology |
|
Infective Endocarditis
|
311 |
Infections- Cardiovascular System |
|
Inflammation
|
225, 229 |
Disease, Immunity & Epidemiology |
|
Influenza
|
299 |
Infections- Respiratory System |
|
Influenza virus
|
271 |
Microbes |
|
Innate Immunity
|
220 - 229 |
Disease, Immunity & Epidemiology |
|
Inoculation
|
179 - 180 |
Acellular Infectious Agents |
|
Integrase
|
177 |
Acellular Infectious Agents |
|
Intercalating Agents
|
138 |
Microbial Genetics |
|
Introns
|
130 |
Microbial Genetics |
|
Invasion Factors
|
218 |
Disease, Immunity & Epidemiology |
|
Ion
|
17 |
Foundations |
|
Ionic Bond
|
18 |
Foundations |
|
Ionizing Radiation
|
138, 187 |
Microbial Genetics |
|
Isoniazid
|
197 |
Control of Microbial Growth |
|
Isotonic Solution
|
68 - 71 |
Prokaryote & Eukoaryote Cells |
|
Jenner, Edward
|
2 |
Foundations |
|
Kirby-Bauer Disk Diffusion Test
|
203 |
Control of Microbial Growth |
|
Klebsiella pneumoniae
|
272 |
Microbes |
|
Koch, Robert
|
3 - 4 |
Foundations |
|
Koch's Postulates
|
4 |
Foundations |
|
Kreb's Cycle
|
87 - 88 |
Microbial Metabolism |
|
Kuru
|
337 |
Infections- Nervous System |
|
Lac Operon
|
151 - 152 |
Microbial Genetics |
|
Lactic Acid Fermentation
|
92 - 93 |
Microbial Metabolism |
|
Lactobacillus acidophilus
|
272 |
Microbes |
|
Lactoferrin
|
223 |
Disease, Immunity & Epidemiology |
|
Lag Phase
|
103-104 |
Microbial Growth |
|
Latent Disease
|
209 |
Disease, Immunity & Epidemiology |
|
Latent Viral Infection
|
178 |
Acellular Infectious Agents |
|
Lectin Pathway
|
224 |
Disease, Immunity & Epidemiology |
|
Legionella pneumophila
|
272 |
Microbes |
|
Legionnaires' Disease
|
297 |
Infections- Respiratory System |
|
Leprosy
|
332 |
Infections- Nervous System |
|
Leptospira spp.
|
273 |
Microbes |
|
Leptospirosis
|
361 |
Infections- Genitourinary System |
|
Light Repair
|
139 |
Microbial Genetics |
|
Light-Dependent Reactions
|
95 |
Microbial Metabolism |
|
Light-Independent Reactions
|
95 |
Microbial Metabolism |
|
Lincosamides
|
194 |
Control of Microbial Growth |
|
Lipid A
|
51, 219 |
Prokaryote & Eukoaryote Cells; Disease, Immunity & Epidemiology |
|
Lipid Catabolism
|
94 |
Microbial Metabolism |
|
Lipids
|
26 |
Foundations |
|
Lipopeptides
|
196 |
Control of Microbial Growth |
|
Lipopolysaccharide (LPS)
|
51 - 52 |
Prokaryote & Eukoaryote Cells |
|
Lipoteichoic Acid
|
51 - 52 |
Prokaryote & Eukoaryote Cells |
|
Lister, Joseph
|
3 |
Foundations |
|
Listeria monocytogenes
|
273 |
Microbes |
|
Listeriosis
|
331 |
Infections- Nervous System |
|
Live Attentuated Vaccine
|
245 |
Disease, Immunity & Epidemiology |
|
Local Infection
|
211 |
Disease, Immunity & Epidemiology |
|
Log Phase
|
103-104 |
Microbial Growth |
|
Lyme Disease
|
316 |
Infections- Cardiovascular System |
|
Lysogenic Cycle
|
170 - 171 |
Acellular Infectious Agents |
|
Lysosomes
|
61 |
Prokaryote & Eukoaryote Cells |
|
Lysozyme
|
222 |
Disease, Immunity & Epidemiology |
|
Lytic Cycle
|
168 - 169, 171 |
Acellular Infectious Agents |
|
Macrolides
|
194 |
Control of Microbial Growth |
|
Macromolecules
|
23 - 27 |
Foundations |
|
Macrophages
|
226 |
Disease, Immunity & Epidemiology |
|
Magnification
|
28 |
Foundations |
|
Major Histocompatibility Complexes (MHCs)
|
235 |
Disease, Immunity & Epidemiology |
|
Malaria
|
324 |
Infections- Cardiovascular System |
|
Measles
|
302 |
Infections- Respiratory System |
|
Measles virus
|
273 |
Microbes |
|
Mechanical Vector
|
214 |
Disease, Immunity & Epidemiology |
|
Mediterranean Fever
|
312 |
Infections- Cardiovascular System |
|
Membrane Attack Complex (MAC)
|
225 |
Disease, Immunity & Epidemiology |
|
Membrane Filtration Technique
|
108 |
Microbial Growth |
|
Membrane Function Inhibitors
|
196 |
Control of Microbial Growth |
|
Membrane Transport
|
67 - 72 |
Prokaryote & Eukoaryote Cells |
|
Meningitis
|
328 |
Infections- Nervous System |
|
Mesophiles
|
116 |
Microbial Growth |
|
Metabolic Pathway Inhibitors
|
197 |
Control of Microbial Growth |
|
Methanobacterium
|
274 |
Microbes |
|
Microaerophiles
|
114-115 |
Microbial Growth |
|
Microbiota/Microbiome
|
215 |
Disease, Immunity & Epidemiology |
|
Microscopes
|
28 - 32 |
Foundations |
|
Minimal Bactericidial Concentration (MBC)
|
203 |
Control of Microbial Growth |
|
Minimal Inhibitory Concentration (MIC)
|
203 |
Control of Microbial Growth |
|
Mismatch Repair
|
139 |
Microbial Genetics |
|
Missense Mutation
|
136 - 137 |
Microbial Genetics |
|
Mitochondria
|
62, 65 - 66 |
Prokaryote & Eukoaryote Cells |
|
Mode of Action
|
191 |
Control of Microbial Growth |
|
Moist Heat Sterilization
|
185 |
Control of Microbial Growth |
|
Mold
|
14 |
Foundations |
|
Molecular Cloning
|
154 - 158 |
Microbial Genetics |
|
Monobactams
|
193 |
Control of Microbial Growth |
|
Monoclonal Antibodies
|
248, 250 |
Disease, Immunity & Epidemiology |
|
Monocytes
|
226 |
Disease, Immunity & Epidemiology |
|
Mononucleosis
|
317 |
Infections- Cardiovascular System |
|
Morbidity
|
253 |
Disease, Immunity & Epidemiology |
|
Mortality
|
253 |
Disease, Immunity & Epidemiology |
|
Most Probable Method (MPN) Method
|
109-110 |
Microbial Growth |
|
Mucociliary Escalator
|
221 |
Disease, Immunity & Epidemiology |
|
Mucous Membranes
|
221 |
Disease, Immunity & Epidemiology |
|
Multidrug Resistant Microbes
|
202 |
Control of Microbial Growth |
|
Mumps
|
343 |
Infections- Gastrointestinal System |
|
Mumps virus
|
274 |
Microbes |
|
Mutagen
|
138 |
Microbial Genetics |
|
Mutations
|
136 - 141 |
Microbial Genetics |
|
Mutualism
|
216 |
Disease, Immunity & Epidemiology |
|
Mycobacterium leprae
|
274 |
Microbes |
|
Mycobacterium tuberculosis
|
275 |
Microbes |
|
Mycolic Acid
|
35, 39, 51 |
Foundations; Prokaryote & Eukoaryote Cells |
|
Mycoplasma pneumoniae
|
275 |
Microbes |
|
Mycotoxin
|
219 |
Disease, Immunity & Epidemiology |
|
Naegleria fowleri
|
275 |
Microbes |
|
Narrow-Spectrum
|
191 |
Control of Microbial Growth |
|
Natural Killer Cells
|
226 |
Disease, Immunity & Epidemiology |
|
Necrotizing Fasciitis
|
373 |
Infections- Skin & Eye System |
|
Negative Stain
|
34 |
Foundations |
|
Negative-Sense Single-Strand RNA virus (-ssRNA)
|
176 |
Acellular Infectious Agents |
|
Neisseria gonorrhoeae
|
276 |
Microbes |
|
Neisseria meningitidis
|
276 |
Microbes |
|
Neurocysticercosis
|
339 |
Infections- Nervous System |
|
Neutral
|
21 |
Foundations |
|
Neutralism
|
216 |
Disease, Immunity & Epidemiology |
|
Neutralization
|
234 |
Disease, Immunity & Epidemiology |
|
Neutron
|
16 |
Foundations |
|
Neutrophiles
|
117 |
Microbial Growth |
|
Neutrophils
|
226 |
Disease, Immunity & Epidemiology |
|
Nitrogen Cycle
|
98-99 |
Microbial Metabolism |
|
Nitroimidazoles
|
195 |
Control of Microbial Growth |
|
Noncommunicable Disease
|
206 |
Disease, Immunity & Epidemiology |
|
Noncompetitive Inhibitor
|
80 - 81 |
Microbial Metabolism |
|
Noninfectious Disease
|
206 |
Disease, Immunity & Epidemiology |
|
Nonionizing Radiation
|
138, 187 |
Microbial Genetics |
|
Nonpolar Covalent Bond
|
18 |
Foundations |
|
Nonsense Codon
|
131 |
Microbial Genetics |
|
Nonsense Mutation
|
136 - 137 |
Microbial Genetics |
|
Norovirus
|
276 |
Microbes |
|
Nosocomial Disease
|
206 |
Disease, Immunity & Epidemiology |
|
Notifiable Diseases
|
257 |
Disease, Immunity & Epidemiology |
|
Nuclear Envelope
|
58 |
Prokaryote & Eukoaryote Cells |
|
Nuclear Pores
|
58 |
Prokaryote & Eukoaryote Cells |
|
Nucleic Acid Amplification Tests
|
162 - 163, 181 |
Microbial Genetics; Acellular Infectious Agents |
|
Nucleic Acid Synthesis Inhibitors
|
195 |
Control of Microbial Growth |
|
Nucleic Acid Vaccine
|
245 |
Disease, Immunity & Epidemiology |
|
Nucleic Acids
|
27, 120 - 122 |
Foundations; Microbial Genetics |
|
Nucleoid
|
46 |
Prokaryote & Eukoaryote Cells |
|
Nucleolus
|
58 |
Prokaryote & Eukoaryote Cells |
|
Nucleoside Analogs
|
138 |
Microbial Genetics |
|
Nucleosome
|
58 |
Prokaryote & Eukoaryote Cells |
|
Nucleotide Excision Repair
|
139 |
Microbial Genetics |
|
Nucleotide-Modifying Agents
|
138 |
Microbial Genetics |
|
Nucleotides
|
27, 120 - 122 |
Foundations; Microbial Genetics |
|
Nucleus
|
58 |
Prokaryote & Eukoaryote Cells |
|
Numerical Aperture
|
28 |
Foundations |
|
Obligate Aerobes
|
114-115 |
Microbial Growth |
|
Obligate Anaerobes
|
114-115 |
Microbial Growth |
|
Okazaki Fragments
|
125 - 126 |
Microbial Genetics |
|
Operator
|
147 - 152 |
Microbial Genetics |
|
Operon
|
147 - 152 |
Microbial Genetics |
|
Opportunistic Infection
|
200, 211 |
Control of Microbial Growth; Control of Microbial Growth |
|
Opsonization
|
225, 234 |
Disease, Immunity & Epidemiology |
|
Origin of Replication
|
101-102 |
Microbial Growth |
|
Osmosis
|
68 - 71 |
Prokaryote & Eukoaryote Cells |
|
Osmotic Pressure
|
68, 186 |
Prokaryote & Eukoaryote Cells; Control of Microbial Growth |
|
Otitis Externa
|
375 |
Infections- Skin & Eye System |
|
Otitis Media
|
294 |
Infections- Respiratory System |
|
Oxidation Reactions
|
75 |
Microbial Metabolism |
|
Oxidation-Reduction Reactions
|
75 |
Microbial Metabolism |
|
Oxidative Phosphorlyation
|
89 - 91 |
Microbial Metabolism |
|
Oxygen Requirements
|
114-115 |
Microbial Growth |
|
Oxygenic Photosynthesis
|
96 |
Microbial Metabolism |
|
Palisades
|
44 |
Prokaryote & Eukoaryote Cells |
|
Pandemic Disease
|
254 |
Disease, Immunity & Epidemiology |
|
Papillomas
|
377 |
Infections- Skin & Eye System |
|
Parasites
|
13 |
Foundations |
|
Parasitism
|
216 |
Disease, Immunity & Epidemiology |
|
Parvovirus B19
|
276 |
Microbes |
|
Passive Artificial Immunity
|
244 |
Disease, Immunity & Epidemiology |
|
Passive Natural Immunity
|
244 |
Disease, Immunity & Epidemiology |
|
Passive Transport
|
67 - 71 |
Prokaryote & Eukoaryote Cells |
|
Pasteur, Louis
|
2 |
Foundations |
|
Pasteurization
|
2, 185 |
Foundations; Control of Microbial Growth |
|
Pathogen-Associated Molecular Patterns (PAMPs)
|
227 |
Disease, Immunity & Epidemiology |
|
Pattern-Recognition Receptors (PRRs)
|
227 |
Disease, Immunity & Epidemiology |
|
Penicillins
|
193 |
Control of Microbial Growth |
|
Penicillium spp.
|
277 |
Microbes |
|
Peptic Ulcer Disease (PUD)
|
351 |
Infections- Gastrointestinal System |
|
Peptidoglycan
|
51 - 52 |
Prokaryote & Eukoaryote Cells |
|
Perforins
|
226, 238 |
Disease, Immunity & Epidemiology |
|
Peridontal Diseases
|
342 |
Infections- Gastrointestinal System |
|
Period of Convalescence
|
207 - 208 |
Disease, Immunity & Epidemiology |
|
Period of Decline
|
207 - 208 |
Disease, Immunity & Epidemiology |
|
Period of Illness
|
207 - 208 |
Disease, Immunity & Epidemiology |
|
Periods of an Infectious Disease
|
207 - 208 |
Disease, Immunity & Epidemiology |
|
Peroxisomes
|
61 |
Prokaryote & Eukoaryote Cells |
|
Peroxygens
|
189 |
Control of Microbial Growth |
|
Persistant Viral Infection
|
178 |
Acellular Infectious Agents |
|
Pertussis
|
296 |
Infections- Respiratory System |
|
pH
|
21 - 22 |
Foundations |
|
pH Scale
|
21 - 22 |
Foundations |
|
Phagocytosis
|
72, 227 - 228 |
Prokaryote & Eukoaryote Cells; Disease, Immunity & Epidemiology |
|
Phase-Contrast Microscope
|
31 |
Foundations |
|
Phenolics
|
188 |
Control of Microbial Growth |
|
Phenotype
|
123 |
Microbial Genetics |
|
Phospholipid Bilayer
|
49 - 50 |
Prokaryote & Eukoaryote Cells |
|
Phospholipids
|
26, 49 - 50 |
Foundations; Prokaryote & Eukoaryote Cells |
|
Phosphorus Cycle
|
100 |
Microbial Metabolism |
|
Photophosphorylation
|
95 |
Microbial Metabolism |
|
Photoreactivation
|
139 |
Microbial Genetics |
|
Photosynthesis
|
95 - 96 |
Microbial Metabolism |
|
Phototroph
|
82 |
Microbial Metabolism |
|
Phylogeny
|
7 |
Foundations |
|
Pili/Pilus
|
53 |
Prokaryote & Eukoaryote Cells |
|
Pink Eye
|
376 |
Infections- Skin & Eye System |
|
Pinocytosis
|
72 |
Prokaryote & Eukoaryote Cells |
|
Pinworm
|
358 |
Infections- Gastrointestinal System |
|
Plague
|
314 |
Infections- Cardiovascular System |
|
Plasma Membrane
|
49 - 50, 63 |
Prokaryote & Eukoaryote Cells |
|
Plasmids
|
46, 144 - 145, 156 - 158 |
Prokaryote & Eukoaryote Cells; Microbial Genetics |
|
Plasmodium spp.
|
277 |
Microbes |
|
Plasmolysis
|
69, 186 |
Prokaryote & Eukoaryote Cells; Control of Microbial Growth |
|
Plate Count
|
106 |
Microbial Growth |
|
Plating Methods
|
105 |
Microbial Growth |
|
Pneumonia
|
291 |
Infections- Respiratory System |
|
Pneumonic Plague
|
314 |
Infections- Cardiovascular System |
|
Point Mutation
|
136 - 137 |
Microbial Genetics |
|
Polar Covalent Bond
|
18 |
Foundations |
|
Poliomyelitis
|
336 |
Infections- Nervous System |
|
Poliovirus
|
277 |
Microbes |
|
Poly-A Tail
|
130 |
Microbial Genetics |
|
Polyclonal Antibodies
|
248 - 249 |
Disease, Immunity & Epidemiology |
|
Polymerase Chain Reaction (PCR)
|
162 - 163, 181 |
Microbial Genetics; Acellular Infectious Agents |
|
Polymyxins
|
196 |
Control of Microbial Growth |
|
Polypeptide Antibiotics
|
193 |
Control of Microbial Growth |
|
Positive Stain
|
34 |
Foundations |
|
Positive-Sense Single-Strand RNA virus (+ssRNA)
|
176 |
Acellular Infectious Agents |
|
Pour Plate Method
|
105 |
Microbial Growth |
|
Prevalence
|
253 |
Disease, Immunity & Epidemiology |
|
Primary Amoebic Meningoencephalitis (PAM)
|
340 |
Infections- Nervous System |
|
Primary Immune Response
|
243 |
Disease, Immunity & Epidemiology |
|
Primary Infection
|
211 |
Disease, Immunity & Epidemiology |
|
Primary Transcript
|
130 |
Microbial Genetics |
|
Primase
|
124, 126 |
Microbial Genetics |
|
Prions
|
182, 278 |
Acellular Infectious Agents; Microbes |
|
Prodromal Period
|
207 - 208 |
Disease, Immunity & Epidemiology |
|
Prokaryotes
|
8, 42 - 56 |
Foundations; Prokaryote & Eukoaryote Cells |
|
Promoter
|
147 - 148 |
Microbial Genetics |
|
Proofreading
|
139 |
Microbial Genetics |
|
Propagated Spread
|
253 |
Disease, Immunity & Epidemiology |
|
Prophage
|
170 |
Acellular Infectious Agents |
|
Prospective Epidemiology
|
256 |
Disease, Immunity & Epidemiology |
|
Protease
|
177 |
Acellular Infectious Agents |
|
Protein Catabolism
|
94 |
Microbial Metabolism |
|
Protein-Synthesis Inhibitors
|
194 |
Control of Microbial Growth |
|
Proteins
|
24 |
Foundations |
|
Proteus mirabilis
|
278 |
Microbes |
|
Protists
|
6 |
Foundations |
|
Proton
|
16 |
Foundations |
|
Protozoa
|
11 |
Foundations |
|
Provirus
|
177 |
Acellular Infectious Agents |
|
Pseudomonas aeruginosa
|
279 |
Microbes |
|
Psychrophiles
|
116 |
Microbial Growth |
|
Psychrotrophs
|
116 |
Microbial Growth |
|
Pure Cultures
|
3 |
Foundations |
|
Purines
|
120 - 122 |
Microbial Genetics |
|
Pyelonephritis
|
360 |
Infections- Genitourinary System |
|
Pyrimidines
|
120 - 122 |
Microbial Genetics |
|
Quorum Sensing
|
112-113 |
Microbial Growth |
|
Rabies
|
335 |
Infections- Nervous System |
|
Rabies virus
|
279 |
Microbes |
|
Radiation
|
138, 187 |
Microbial Genetics |
|
Receptor-Mediated Endocytosis
|
72 |
Prokaryote & Eukoaryote Cells |
|
Recipent (F- Cells)
|
144 - 145 |
Microbial Genetics |
|
Recombinant DNA Technology
|
153 - 158 |
Microbial Genetics |
|
Redox Reactions
|
75 |
Microbial Metabolism |
|
Reduction Reactions
|
75 |
Microbial Metabolism |
|
Reemerging Infectious Diseases
|
257 |
Disease, Immunity & Epidemiology |
|
Refraction
|
28 |
Foundations |
|
Refrigeration
|
186 |
Control of Microbial Growth |
|
Regulatory Gene
|
147 - 148 |
Microbial Genetics |
|
Regulatory T Cells
|
238 |
Disease, Immunity & Epidemiology |
|
Remitting Fever
|
312 |
Infections- Cardiovascular System |
|
Replica Plating
|
140 |
Microbial Genetics |
|
Repressible Operons
|
149 - 150 |
Microbial Genetics |
|
Repressor
|
147, 149 - 152 |
Microbial Genetics |
|
Reservoir
|
212 |
Disease, Immunity & Epidemiology |
|
Resolution
|
28 |
Foundations |
|
Respiratory syncytial virus (RSV)
|
280, 300 |
Microbes; Infections- Respiratory System |
|
Restriction Enzymes
|
154 - 156 |
Microbial Genetics |
|
Retrospective Epidemiology
|
256 |
Disease, Immunity & Epidemiology |
|
Retrovirus
|
177 |
Acellular Infectious Agents |
|
Reverse Transcriptase
|
177 |
Acellular Infectious Agents |
|
Reversible Reaction
|
73 |
Microbial Metabolism |
|
Rhinoviruses
|
280 |
Microbes |
|
Rhizobium spp.
|
280 |
Microbes |
|
Ribonucleic Acid (RNA)
|
27, 120, 128 - 135 |
Foundations; Microbial Genetics |
|
Ribosomes
|
46, 59, 133 - 135 |
Prokaryote & Eukoaryote Cells; Microbial Genetics |
|
Rickettsia rickettsii
|
281 |
Microbes |
|
Rifamycins
|
195 |
Control of Microbial Growth |
|
Ringworm
|
383 |
Infections- Skin & Eye System |
|
RNA
|
27, 120, 128 - 135 |
Foundations; Microbial Genetics |
|
RNA-Dependent RNA Polymerase
|
176 |
Acellular Infectious Agents |
|
Rocky Mountain Spotted Fever
|
315 |
Infections- Cardiovascular System |
|
Roseola
|
379 |
Infections- Skin & Eye System |
|
Rotavirus
|
281 |
Microbes |
|
Route of Administration
|
192 |
Control of Microbial Growth |
|
Rubella
|
303 |
Infections- Respiratory System |
|
Rubella virus
|
281 |
Microbes |
|
Rubeola
|
302 |
Infections- Respiratory System |
|
Saccharomyces cerevisiae
|
282 |
Microbes |
|
Saliva
|
222 |
Disease, Immunity & Epidemiology |
|
Salmonella spp.
|
282 |
Microbes |
|
Salmonellosis
|
346 |
Infections- Gastrointestinal System |
|
Sanitization
|
183 |
Control of Microbial Growth |
|
Sarcinae
|
43 |
Prokaryote & Eukoaryote Cells |
|
SARS-Coronavirus-2
|
282 |
Microbes |
|
Saturated Fatty Acids
|
26 |
Foundations |
|
Scanning Probe Microscope
|
32 |
Foundations |
|
Schistosoma spp.
|
283 |
Microbes |
|
Schistosomiasis
|
327 |
Infections- Cardiovascular System |
|
Sebum
|
222 |
Disease, Immunity & Epidemiology |
|
Secondary Immune Response
|
243 |
Disease, Immunity & Epidemiology |
|
Secondary Infection
|
200, 211 |
Control of Microbial Growth; Control of Microbial Growth |
|
Selective Media
|
119 |
Microbial Growth |
|
Selective Permeability
|
49 |
Prokaryote & Eukoaryote Cells |
|
Selective Toxicity
|
191 |
Control of Microbial Growth |
|
Semiconservative Replication
|
124 - 126 |
Microbial Genetics |
|
Sepsis
|
309 |
Infections- Cardiovascular System |
|
Septic Shock
|
309 |
Infections- Cardiovascular System |
|
Septicemic Plague
|
314 |
Infections- Cardiovascular System |
|
Serial Dilution
|
106-107 |
Microbial Growth |
|
Serological Assays
|
181, 251 - 252 |
Acellular Infectious Agents; Disease, Immunity & Epidemiology |
|
Serratia marcescens
|
283 |
Microbes |
|
Shigella spp.
|
284 |
Microbes |
|
Shigellosis
|
345 |
Infections- Gastrointestinal System |
|
Shingles
|
305 |
Infections- Respiratory System |
|
Siderophores
|
218 |
Disease, Immunity & Epidemiology |
|
Signs
|
205 |
Disease, Immunity & Epidemiology |
|
Silent Mutation
|
136 - 137 |
Microbial Genetics |
|
Simple Diffusion
|
67 |
Prokaryote & Eukoaryote Cells |
|
Simple Stain
|
34 |
Foundations |
|
Single Replacement Reaction
|
73 |
Microbial Metabolism |
|
Single-Stranded DNA virus (ssDNA)
|
177 |
Acellular Infectious Agents |
|
Sixth Disease
|
379 |
Infections- Skin & Eye System |
|
Skin
|
221 |
Disease, Immunity & Epidemiology |
|
Sleeping Sickness
|
338 |
Infections- Nervous System |
|
Slime Layer
|
53 |
Prokaryote & Eukoaryote Cells |
|
Smallpox
|
382 |
Infections- Skin & Eye System |
|
Smallpox virus
|
284 |
Microbes |
|
Solute
|
19 |
Foundations |
|
Solvent
|
19 |
Foundations |
|
Specialized Transduction
|
142, 172 - 173 |
Microbial Genetics |
|
Spikes
|
165 |
Acellular Infectious Agents |
|
Spirillum
|
42 |
Prokaryote & Eukoaryote Cells |
|
Spirochete
|
42 |
Prokaryote & Eukoaryote Cells |
|
Spontaenous Generation
|
1 |
Foundations |
|
Spontaneous Mutations
|
136 |
Microbial Genetics |
|
Sporadic Disease
|
254 |
Disease, Immunity & Epidemiology |
|
Sporulation
|
47 - 48 |
Prokaryote & Eukoaryote Cells |
|
Spread Plate Method
|
105 |
Microbial Growth |
|
Stages of Pathogenesis
|
210 |
Disease, Immunity & Epidemiology |
|
Stains
|
34 - 41 |
Foundations |
|
Staphylococcal Food Poisoning
|
344 |
Infections- Gastrointestinal System |
|
Staphylococci
|
43 |
Prokaryote & Eukoaryote Cells |
|
Staphylococcus aureus
|
284 |
Microbes |
|
Start Codon
|
131 |
Microbial Genetics |
|
Stationary Phase
|
103-104 |
Microbial Growth |
|
Sterilization
|
183 |
Control of Microbial Growth |
|
Sterols
|
26 |
Foundations |
|
Sticky Ends
|
154 - 156 |
Microbial Genetics |
|
Stop Codon
|
131 - 132 |
Microbial Genetics |
|
Streopcoccal Pharyngitis
|
292 |
Infections- Respiratory System |
|
Strep Throat
|
292 |
Infections- Respiratory System |
|
Streptobacilli
|
44 |
Prokaryote & Eukoaryote Cells |
|
Streptococci
|
43 |
Prokaryote & Eukoaryote Cells |
|
Streptococcus agalactiae
|
285 |
Microbes |
|
Streptococcus mutans
|
285 |
Microbes |
|
Streptococcus pneumoniae
|
285 |
Microbes |
|
Streptococcus pyogenes
|
286 |
Microbes |
|
Substrate
|
78 - 81 |
Microbial Metabolism |
|
Subunit Vaccine
|
245 |
Disease, Immunity & Epidemiology |
|
Sulfolobus spp.
|
286 |
Microbes |
|
Sulfonamides
|
197 |
Control of Microbial Growth |
|
Sulfur Cycle
|
100 |
Microbial Metabolism |
|
Supercritical Fluids
|
189 |
Control of Microbial Growth |
|
Superinfection
|
200, 211 |
Control of Microbial Growth; Control of Microbial Growth |
|
Surfactants
|
188 |
Control of Microbial Growth |
|
Sweat
|
222 |
Disease, Immunity & Epidemiology |
|
Swimmer's Ear
|
375 |
Infections- Skin & Eye System |
|
Symboiosis
|
216 |
Disease, Immunity & Epidemiology |
|
Symptoms
|
205 |
Disease, Immunity & Epidemiology |
|
Syndrome
|
205 |
Disease, Immunity & Epidemiology |
|
Synergism
|
192 |
Control of Microbial Growth |
|
Synthesis Reaction
|
73 |
Microbial Metabolism |
|
Syphilis
|
365 |
Infections- Genitourinary System |
|
Systemic Infection
|
211 |
Disease, Immunity & Epidemiology |
|
Taenia spp.
|
287 |
Microbes |
|
Taeniasis
|
359 |
Infections- Gastrointestinal System |
|
Taxonomy
|
5 |
Foundations |
|
Teichoic Acid
|
51 |
Prokaryote & Eukoaryote Cells |
|
Telomeres
|
127 |
Microbial Genetics |
|
Tetanus
|
329 |
Infections- Nervous System |
|
Tetracyclines
|
194 |
Control of Microbial Growth |
|
Tetrads
|
43 |
Prokaryote & Eukoaryote Cells |
|
Thermal Death Point
|
185 |
Control of Microbial Growth |
|
Thermal Death Time
|
185 |
Control of Microbial Growth |
|
Thermophiles
|
116 |
Microbial Growth |
|
Thymic Selection
|
230 |
Disease, Immunity & Epidemiology |
|
Thymine Dimers
|
138 - 139, 187 |
Microbial Genetics |
|
Tinea Infections
|
383 |
Infections- Skin & Eye System |
|
Toll-Like Receptors (TLRs)
|
227 |
Disease, Immunity & Epidemiology |
|
Toxic Shock Syndrome (TSS)
|
310 |
Infections- Cardiovascular System |
|
Toxins
|
218 - 219 |
Disease, Immunity & Epidemiology |
|
Toxoid Vaccine
|
245 |
Disease, Immunity & Epidemiology |
|
Toxoplasma gondii
|
287 |
Microbes |
|
Toxoplasmosis
|
325 |
Infections- Cardiovascular System |
|
Transcription
|
128 - 130 |
Microbial Genetics |
|
Transduction
|
142 - 143, 172 - 173 |
Microbial Genetics |
|
Transferrin
|
223 |
Disease, Immunity & Epidemiology |
|
Transformation
|
142 - 143 |
Microbial Genetics |
|
Transgenic
|
153 |
Microbial Genetics |
|
Transition Reaction
|
86 |
Microbial Metabolism |
|
Translation
|
131 - 135 |
Microbial Genetics |
|
Translocation
|
134 - 135 |
Microbial Genetics |
|
Transmissible Spongiform Encephalopathies (TSEs)
|
337 |
Infections- Nervous System |
|
Transposons
|
146 |
Microbial Genetics |
|
Treponema pallidum
|
288 |
Microbes |
|
Tricarboxylic Acid Cycle
|
87 - 88 |
Microbial Metabolism |
|
Trichomonas vaginalis
|
288 |
Microbes |
|
Trichomoniasis
|
369 |
Infections- Genitourinary System |
|
Triglycerides
|
26 |
Foundations |
|
Trp Operon
|
149 - 150 |
Microbial Genetics |
|
Trypanosoma spp.
|
288 |
Microbes |
|
Tuberculosis
|
295 |
Infections- Respiratory System |
|
Typhoid Fever
|
347 |
Infections- Gastrointestinal System |
|
Undulant Fever
|
312 |
Infections- Cardiovascular System |
|
Unsaturated Fatty Acids
|
26 |
Foundations |
|
Urinary Tract Infection (UTI)
|
360 |
Infections- Genitourinary System |
|
Use-Dilution Test
|
190 |
Control of Microbial Growth |
|
Vaccines
|
2, 245 |
Foundations; Disease, Immunity & Epidemiology |
|
Vacuoles
|
61 |
Prokaryote & Eukoaryote Cells |
|
Vaginal Candidiasis
|
368 |
Infections- Genitourinary System |
|
Valley Fever
|
307 |
Infections- Respiratory System |
|
Van Leeuwenhoek, Antonie
|
1 |
Foundations |
|
Varicella zoster virus (VZV)
|
289 |
Microbes |
|
Vector Transmission
|
214 |
Disease, Immunity & Epidemiology |
|
Vectors
|
157 - 158 |
Microbial Genetics |
|
Vegetative Cell
|
47 |
Prokaryote & Eukoaryote Cells |
|
Vehicle Transmission
|
214 |
Disease, Immunity & Epidemiology |
|
Vibrio
|
42 |
Prokaryote & Eukoaryote Cells |
|
Vibrio cholerae
|
289 |
Microbes |
|
Viral Growth Curve
|
179 - 180 |
Acellular Infectious Agents |
|
Viral Replication
|
168 - 177 |
Acellular Infectious Agents |
|
Viral Titer
|
179 |
Acellular Infectious Agents |
|
Virion
|
164 |
Acellular Infectious Agents |
|
Viroids
|
182 |
Acellular Infectious Agents |
|
Virulence
|
217 - 218 |
Disease, Immunity & Epidemiology |
|
Virulence Factors
|
217 - 218 |
Disease, Immunity & Epidemiology |
|
Virus Shapes/Structures
|
166 - 167 |
Acellular Infectious Agents |
|
Viruses
|
15, 164 - 181 |
Foundations; Microbial Genetics |
|
Warts
|
377 |
Infections- Skin & Eye System |
|
Water
|
19 - 20 |
Foundations |
|
Waterborne Transmission
|
214 |
Disease, Immunity & Epidemiology |
|
Weil's Disease
|
361 |
Infections- Genitourinary System |
|
West Nile virus
|
289 |
Microbes |
|
Wet Mount
|
33 |
Foundations |
|
Whooping Cough
|
296 |
Infections- Respiratory System |
|
Wobble Position
|
131 |
Microbial Genetics |
|
Wolbachia spp.
|
290 |
Microbes |
|
World Health Organization (WHO)
|
257 |
Disease, Immunity & Epidemiology |
|
Yeast
|
14 |
Foundations |
|
Yeast Infection
|
368 |
Infections- Genitourinary System |
|
Yellow Fever
|
319 |
Infections- Cardiovascular System |
|
Yellow Fever virus
|
290 |
Microbes |
|
Yersinia pestis
|
290 |
Microbes |
|
Zika
|
334 |
Infections- Nervous System |
|
Zika virus
|
290 |
Microbes |
|
Zone of Inhibition
|
203 |
Control of Microbial Growth |
|
Zoonotic Disease
|
206 |
Disease, Immunity & Epidemiology |
